TY - JOUR
T1 - Two cases of pancreatic neuroendocrine tumors with ectopic ACTH syndrome during their disease course
AU - Murakami, Masatoshi
AU - Hirahata, Keisuke
AU - Fujimori, Nao
AU - Yamamoto, Takeo
AU - Oda, Yoshinao
AU - Kozono, Shingo
AU - Ueda, Keijiro
AU - Ito, Testuhide
AU - Nakamura, Masafumi
AU - Ogawa, Yoshihiro
N1 - Publisher Copyright:
© Japanese Society of Gastroenterology 2024.
PY - 2024/4
Y1 - 2024/4
N2 - Pancreatic neuroendocrine tumors (PanNETs) are rare malignant tumors that occur in the pancreas. They are divided into functioning and non-functioning tumors based on the presence or absence of their specific hormonal hyper-expression symptoms. Adrenocorticotropic hormone (ACTH)-producing PanNETs are rare, functional tumors, and their clinical characteristics and outcomes have not been well reported. Here, we report the cases of two patients with PanNETs who presented with ectopic ACTH syndrome (EAS) during the course of their disease. Case 1 involved a non-functioning PanNET at the time of surgery. During treatment for recurrent liver metastases, the patient presented with EAS and tumor-associated hypercalcemia, probably due to ACTH and parathyroid hormone-related peptide (PTHrP) production from the liver tumor. Case 2 was a gastrinoma, and similar to Case 1, this patient presented with EAS during the treatment of recurrent liver metastases. It is not uncommon for patients with PanNETs to have multiple hormones and develop secondary hormone secretion during their disease course, although tumor phenotypes differ between primary and metastatic sites. In patients with functioning PanNETs, symptom control with anti-hormonal therapy is essential, in addition to anti-tumor therapy, especially for EAS, which is an endocrine emergency disease that requires prompt diagnosis and treatment.
AB - Pancreatic neuroendocrine tumors (PanNETs) are rare malignant tumors that occur in the pancreas. They are divided into functioning and non-functioning tumors based on the presence or absence of their specific hormonal hyper-expression symptoms. Adrenocorticotropic hormone (ACTH)-producing PanNETs are rare, functional tumors, and their clinical characteristics and outcomes have not been well reported. Here, we report the cases of two patients with PanNETs who presented with ectopic ACTH syndrome (EAS) during the course of their disease. Case 1 involved a non-functioning PanNET at the time of surgery. During treatment for recurrent liver metastases, the patient presented with EAS and tumor-associated hypercalcemia, probably due to ACTH and parathyroid hormone-related peptide (PTHrP) production from the liver tumor. Case 2 was a gastrinoma, and similar to Case 1, this patient presented with EAS during the treatment of recurrent liver metastases. It is not uncommon for patients with PanNETs to have multiple hormones and develop secondary hormone secretion during their disease course, although tumor phenotypes differ between primary and metastatic sites. In patients with functioning PanNETs, symptom control with anti-hormonal therapy is essential, in addition to anti-tumor therapy, especially for EAS, which is an endocrine emergency disease that requires prompt diagnosis and treatment.
KW - Cushing’s syndrome
KW - Ectopic ACTH syndrome
KW - PTHrP
KW - Pancreatic neuroendocrine tumor
KW - Secondary hormone secretion
UR - http://www.scopus.com/inward/record.url?scp=85182640888&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85182640888&partnerID=8YFLogxK
U2 - 10.1007/s12328-023-01908-5
DO - 10.1007/s12328-023-01908-5
M3 - Article
C2 - 38244178
AN - SCOPUS:85182640888
SN - 1865-7257
VL - 17
SP - 363
EP - 370
JO - Clinical Journal of Gastroenterology
JF - Clinical Journal of Gastroenterology
IS - 2
ER -